Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
5,563
EUR
|
1,900
EUR
|
| Cash flows from (used in) operations before changes in working capital |
71,990
EUR
|
97,494
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
45,261
EUR
|
8,004
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
73,183
EUR
|
21,472
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
1,020
EUR
|
977,000
EUR
|
| Adjustments for amortisation expense |
10,627
EUR
|
9,039
EUR
|
| Adjustments for depreciation expense |
35,209
EUR
|
32,788
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
190,000
EUR
|
1,169
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
136,000
EUR
|
10,000
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
3,801
EUR
|
4,101
EUR
|
| Income taxes paid, classified as operating activities |
16,906
EUR
|
15,015
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
2,429
EUR
|
6,752
EUR
|
| Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations |
2,565
EUR
|
6,579
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Payments for debt issue costs |
120,000
EUR
|
-
EUR
|